AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Endonovo Therapeutics, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
31.88K
AVG Volume
654.08K
Trailing/Forward PE
-0.2/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M2016201720182019202020212022202320242025
ENDV Revenue (USD) by year
PeriodRevenue (USD)
20250
202410.04K
2023140.24K
2022135.35K
202173.11K
2020165.8K
2019310.16K
201883.26K
20170
20161.1M
Net Income (USD)
-20M-10M010M2016201720182019202020212022202320242025
ENDV Net Income (USD) by year
PeriodNet Income (USD)
2025-2.18M
2024-2.8M
20236.92M
2022-18.47M
2021-3.1M
2020-395.58K
2019-17.31M
2018-6.44M
2017-10.81M
2016-5.32M
Operating Income (USD)
-6M-4M-2M02016201720182019202020212022202320242025
ENDV Operating Income (USD) by year
PeriodOperating Income (USD)
2025-945.77K
2024-1.56M
2023-2.92M
2022-3.26M
2021-2.23M
2020-2.91M
2019-3.81M
2018-4.16M
2017-4.6M
2016-5.41M
EBITDA (USD)
-20M-10M010M2016201720182019202020212022202320242025
ENDV EBITDA (USD) by year
PeriodEBITDA (USD)
2025-938.77K
2024-941.4K
20238.85M
2022-16.51M
2021-1.51M
20202.34M
2019-10.57M
2018-3.51M
2017-4.59M
2016-5.4M
Cash Flows (USD)
-3M-2M-1M01M2016201720182019202020212022202320242025
ENDV Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-17.97K
2024100.48K
2023121.87K
2022-678.84K
2021-986.58K
2020-741.59K
2019-2.54M
2018-2.88M
2017-2.99M
2016-2.46M
EPS (USD)
-30-20-100102016201720182019202020212022202320242025
ENDV EPS (USD) by year
PeriodEPS (USD)
2025-0
2024-0.01
2023-0
2022-0.13
2021-0.08
2020-0.51
2019-27.66
2018-17.85
20176.65
2016-6.05
Expenses (USD)
02M4M6MR&DSG&ACapex2016201720182019202020212022202320242025
ENDV Expenses (USD) by year
PeriodExpenses (USD)
2025697.2K
2024783.01K
20232.4M
20222.74M
20211.64M
20202.37M
20195.27M
20184.52M
20174.68M
20165.41M
Cash & Debt (USD)
02.5M5M7.5M10MCashLong Term DebtShort Term Debt2016201720182019202020212022202320242025
ENDV Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202512
20243
20231.84K
202298
202185.94K
202013.42K
201918.89K
2018379.15K
201790.17K
201655.53K
Debt ratios
-1.5-1-0.5020182019202020212022202320242025
ENDV Debt ratios by year
PeriodDebt ratios
2025-0.73
2024-0.68
2023-1.04
2022-0.27
2021-0.54
2020-0.41
2019-0.28
2018-0.37
Margins
-8000%-6000%-4000%-2000%0%2000%20162018201920202021202220232024
ENDV Margins by year
PeriodMargins
2024-6125.64%
2023-136.23%
202292.62%
202179.5%
202060.57%
201969.89%
201884.47%
2016100%
Return on Capital
-50%0%50%100%150%2016201720182019202020212022202320242025
ENDV Return on Capital by year
PeriodReturn on Capital
20257.54%
202410.44%
2023-28.73%
202257.41%
202119.68%
20202.75%
201984.45%
201856.5%
2017113.19%
201662.09%
Shares Outstanding
0500M1B1.5B2B2016201720182019202020212022202320242025
ENDV Shares Outstanding by year
PeriodShares Outstanding
20251.81B
2024543.87M
2023318.75M
2022213.23M
202174.5M
202016.14M
2019777.25K
2018369.23K
2017263.54K
2016123.14K
Book Value Per Share (USD)
-80-60-40-2002016201720182019202020212022202320242025
ENDV Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-0.02
2024-0.05
2023-0.08
2022-0.15
2021-0.21
2020-0.89
2019-26.38
2018-30.85
2017-36.24
2016-69.53
Total Assets (USD)
02M4M6M2016201720182019202020212022202320242025
ENDV Total Assets (USD) by year
PeriodTotal Assets (USD)
202519.3K
202419.29K
2023639.66K
20221.28M
20212.01M
20202.61M
20193.27M
20184.24M
20174.61M
2016318.68K
Employee Count
05101520201120122013201420152016201720182019
ENDV Employee Count by year
PeriodEmployee Count
201910
201810
201715
201610
201510
201410
201317
201214
20116
PE Ratio
00.050.10.15med 0.07Apr 24Apr 24May 24May 24May 24Jun 24Jun 24
ENDV PE Ratio by year
PeriodPE Ratio
Jun 240.05
Jun 240.07
Jun 240.04
Jun 240.05
May 240.05
May 240.06
May 240.05
May 240.07
May 240.12
Apr 240.12
Apr 240.12
Apr 240.12
Apr 240.15
Free Cash Flow Yield
-500%0%500%1000%med 38.63%Oct 23Jan 24May 24Aug 24Nov 24Mar 25Jun 25
ENDV Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Jun 2592.38%
Jun 2592.38%
Jun 2592.38%
Jun 25123.17%
May 25184.76%
May 25184.76%
May 2592.38%
May 25123.17%
May 25184.76%
Apr 2592.38%
Apr 2573.9%
Apr 2561.59%
Apr 2592.38%
Mar 25963.39%
Mar 25642.26%
Mar 25642.26%
Mar 25481.69%
Feb 25481.69%
Feb 25963.39%
Feb 25481.69%
Feb 25321.13%
Jan 25321.13%
Jan 25385.35%
Jan 25240.85%
Jan 25240.85%
Jan 25120.42%
Dec 24289.66%
Dec 24289.66%
Dec 24165.52%
Dec 24165.52%
Nov 24165.52%
Nov 24165.52%
Nov 24128.74%
Nov 24115.87%
Nov 24112.49%
Oct 24115.87%
Oct 24128.74%
Oct 24128.74%
Oct 24128.74%
Sep 2446.82%
Sep 2441.8%
Sep 2433.44%
Sep 2442.56%
Aug 2433.44%
Aug 2431.21%
Aug 2448.77%
Aug 2443.96%
Aug 2440.71%
Jul 2439.02%
Jul 2439.02%
Jul 2446.82%
Jul 2452.02%
Jun 2436.41%
Jun 2425.49%
Jun 2447.79%
Jun 2438.23%
May 2434.76%
May 2429.41%
May 2433.54%
May 2425.49%
May 2415.29%
Apr 2414.54%
Apr 2414.59%
Apr 2414.16%
Apr 2411.95%
Mar 24-68.1%
Mar 24-62.09%
Mar 24-60.31%
Mar 24-51.49%
Mar 24-63.97%
Feb 24-58.64%
Feb 24-53.31%
Feb 24-63.97%
Feb 24-35.18%
Jan 24-34.05%
Jan 24-23.72%
Jan 24-21.65%
Jan 24-24.84%
Dec 23-24.26%
Dec 23-24.19%
Dec 23-27.38%
Dec 23-22.65%
Dec 23-20.76%
Nov 23-19.16%
Nov 23-21.91%
Nov 23-20.25%
Nov 23-19.87%
Oct 23-19.16%
Oct 23-17.92%
Oct 23-24.19%
Oct 23-21.48%
Sep 23-19.77%
Sep 23-19.77%
Sep 23-22.42%
Sep 23-20.76%
Sep 23-19.62%
Aug 23-24.67%
Aug 23-28.72%
Aug 23-29%
Aug 23-26.37%
Price to Sales
050100150med 10.83Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25Sep 25
ENDV Price to Sales by year
PeriodPrice to Sales
Sep 2566.1
Sep 2566.1
Sep 2566.1
Sep 2566.1
Aug 2566.1
Aug 2566.1
Aug 25132.2
Aug 2566.1
Aug 25132.2
Jul 25132.2
Jul 25132.2
Jul 25118.98
Jul 2566.1
Jun 2510.83
Jun 2510.83
Jun 2510.83
Jun 258.12
May 255.42
May 255.42
May 2510.83
May 258.12
May 255.42
Apr 2510.83
Apr 2513.54
Apr 2516.25
Apr 2510.83
Mar 253.39
Mar 255.09
Mar 255.09
Mar 256.79
Feb 256.79
Feb 253.39
Feb 256.79
Feb 2510.18
Jan 2510.18
Jan 258.48
Jan 2513.58
Jan 2513.58
Jan 2527.15
Dec 249.05
Dec 249.05
Dec 2415.83
Dec 2415.83
Nov 2415.83
Nov 2415.83
Nov 2420.35
Nov 2422.61
Nov 2423.29
Oct 2422.61
Oct 2420.35
Oct 2420.35
Oct 2420.35
Sep 2410.24
Sep 2411.47
Sep 2414.33
Sep 2411.26
Aug 2414.33
Aug 2415.36
Aug 249.83
Aug 2410.9
Aug 2411.77
Jul 2412.29
Jul 2412.29
Jul 2410.24
Jul 249.21
Jun 242.39
Jun 243.41
Jun 241.82
Jun 242.27
May 242.5
May 242.95
May 242.59
May 243.41
May 245.68
Apr 245.98
Apr 245.95
Apr 246.14
Apr 247.27
Mar 243.62
Mar 243.97
Mar 244.08
Mar 244.78
Mar 243.85
Feb 244.2
Feb 244.62
Feb 243.85
Feb 247
Jan 247.23
Jan 2410.39
Jan 2411.38
Jan 249.92
Dec 2310.15
Dec 2310.73
Dec 239.48
Dec 2311.46
Dec 2312.51
Nov 2313.55
Nov 2311.85
Nov 2312.82
Nov 2313.06
EV/EBITDA
05101520med 15.43Sep 20Dec 20Feb 21Apr 21May 24Jul 24Sep 24
ENDV EV/EBITDA by year
PeriodEV/EBITDA
Sep 248.41
Sep 248.49
Sep 248.68
Sep 248.48
Aug 248.68
Aug 248.75
Aug 248.38
Aug 248.45
Aug 248.51
Jul 248.54
Jul 248.54
Jul 248.41
Jul 248.34
Jun 240.84
Jun 240.85
Jun 240.83
Jun 240.83
May 240.84
May 240.85
May 240.84
May 240.85
May 240.89
Apr 240.89
Apr 240.89
Apr 240.9
Apr 240.91
May 213.06
May 213.09
May 213.09
Apr 213.12
Apr 213.07
Apr 213.04
Apr 2116.82
Apr 2116.78
Mar 2116.95
Mar 2117.19
Mar 2117.32
Mar 2116.7
Feb 2116.95
Feb 2118.38
Feb 2118.63
Feb 2117.46
Jan 2117.48
Jan 2117.09
Jan 2117.55
Jan 2116.91
Dec 2016.33
Dec 2016.83
Dec 2016.74
Dec 2016.9
Dec 2016.54
Nov 2017.72
Nov 2018.21
Nov 2015.36
Nov 2015.71
Oct 2015.88
Oct 2015.65
Oct 2015.49
Oct 2015.68
Oct 2015.84
Sep 2016.14
Sep 2016.19
Sep 2016.14
Sep 2016.04
Aug 2016.14
Aug 2016.29
Price/Operating Cashflow
02.557.510med 1.08May 24Jul 24Sep 24Nov 24Feb 25Apr 25Jun 25
ENDV Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Jun 251.08
Jun 251.08
Jun 251.08
Jun 250.81
May 250.54
May 250.54
May 251.08
May 250.81
May 250.54
Apr 251.08
Apr 251.35
Apr 251.62
Apr 251.08
Mar 250.1
Mar 250.16
Mar 250.16
Mar 250.21
Feb 250.21
Feb 250.1
Feb 250.21
Feb 250.31
Jan 250.31
Jan 250.26
Jan 250.42
Jan 250.42
Jan 250.83
Dec 240.35
Dec 240.35
Dec 240.6
Dec 240.6
Nov 240.6
Nov 240.6
Nov 240.78
Nov 240.86
Nov 240.89
Oct 240.86
Oct 240.78
Oct 240.78
Oct 240.78
Sep 242.14
Sep 242.39
Sep 242.99
Sep 242.35
Aug 242.99
Aug 243.2
Aug 242.05
Aug 242.27
Aug 242.46
Jul 242.56
Jul 242.56
Jul 242.14
Jul 241.92
Jun 242.75
Jun 243.92
Jun 242.09
Jun 242.62
May 242.88
May 243.4
May 242.98
May 243.92
May 246.54
Apr 246.88
Apr 246.85
Apr 247.06
Apr 248.37
Endonovo Therapeutics, Inc.
ENDV
Stockpicker

Video analysis: ENDV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.